Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13100704 | 0.82 | NFKB1 (0.30) | — | |
| SCHEMBL18790800 | 0.80 | TAS2R38 (0.33) | — | |
| SCHEMBL21654953 | 0.79 | — | — | |
| SCHEMBL20016706 | 0.79 | — | — | |
| SCHEMBL18626259 | 0.79 | — | — | |
| SCHEMBL23982848 | 0.77 | — | — | |
| SCHEMBL21874799 | 0.77 | — | — | |
| SCHEMBL20204385 | 0.77 | — | — | |
| SCHEMBL27071433 | 0.76 | — | — | |
| SCHEMBL22580627 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10722875-B2 | Zinc-imidazole complex mixed catalyst and method for producing methyl N-phenyl carbamate using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2020-07-28 | — | — | US | disclosed |
| US-20200061596-A1 | ZINC-IMIDAZOLE COMPLEX MIXED CATALYST AND METHOD FOR PRODUCING METHYL N-PHENYL CARBAMATE USING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200061596-A1 | ZINC-IMIDAZOLE COMPLEX MIXED CATALYST AND METHOD FOR PRODUCING METHYL N-PHENYL CARBAMATE USING THE SAME | JMJD6, ZMYND8, JMJD7 | KEAP1 2868/4885NFE2L2 1683/4885HCAR2 4229/4885 |
| US-10722875-B2 | Zinc-imidazole complex mixed catalyst and method for producing methyl N-phenyl carbamate using the same | JMJD6, ZMYND8, JMJD7 | KEAP1 2868/4885NFE2L2 1683/4885HCAR2 4229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.